Patents Examined by Rachel M. Bennett
  • Patent number: 6267972
    Abstract: Cosmetic/pharmaceutical compositions, well suited for the treatment of a variety of mammalian disorders of, for example, the skin, hair and/or mucous membranes, a manifestation of which is an excess in the synthesis and/or in the release of substance P, e.g., for the treatment of cutaneous disorders and sensitive skin, comprise an effective substance P antagonist amount of at least one &bgr;-adrenergic agonist, e.g., salbutamol, in a cosmetically/pharmaceutically acceptable medium therefor.
    Type: Grant
    Filed: May 12, 1999
    Date of Patent: July 31, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Lionel Breton, Olivier De Lacharriere, Jacques Leclaire
  • Patent number: 6251421
    Abstract: The present invention provides orally administrable pharmaceutical compositions containing an inhibitor of gastrointestinal lipase, and at least one compound selected from the group consisting of psyllium husk, its seeds and leaves thereof. Methods are provided for preventing and treating anal leakage of oil in a patient to whom a composition containing an inhibitor of gastrointestinal lipase is orally administered.
    Type: Grant
    Filed: September 25, 2000
    Date of Patent: June 26, 2001
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6245323
    Abstract: A lamellar particle is coated with an amorphous metal oxide hydrated gel which is then converted into a hydrophobic metal hydroxide-organic composite polymer film. The resulting product can be combined with a powdery film-forming polymer to produce a film-forming composition which can be applied by electrostatic coating. It also has significantly enhanced performance in plastic masterbatching, hydrophobic cosmetic formulations, and liquid paints and numerous other applications where a hydrophobic pigment is advantageous.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: June 12, 2001
    Assignee: Engelhard Corporation
    Inventors: James D. Christie, William C. Howard
  • Patent number: 6238690
    Abstract: Consumable products including seamless capsules having an outer shell made of a carbohydrate material in a glassy state and an inner core.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: May 29, 2001
    Assignee: Warner-Lambert Company
    Inventors: Jesse John Kiefer, Blake Henderson Glenn
  • Patent number: 6238702
    Abstract: A formulation for inducing sustained local anesthesia in a patient comprising a substrate comprising a high load of local anesthetic by weight and an effective amount of a biocompatible, controlled release material to obtain a. reversible nerve blockade or anesthesia effect when implanted or injected in a patient, and a non-toxic glucocorticosteroid agent effective to prolong the duration of the local anesthesia for a time period longer than that obtainable from the substrate without the glucocorticosteroid agent.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: May 29, 2001
    Assignee: Children's Medical Center Corp.
    Inventors: Charles B. Berde, Robert S. Langer, Joanne Curley, Jenny Castillo
  • Patent number: 6235314
    Abstract: Disclosed is a local skeletal muscle relaxant and a non-steroidal anti-inflammatory drug in a topical composition for topical application to a patient for relief of pain. More particularly and in its preferred form, the invention involves a combination of diazepam and diclofenac in a composition for topical application to the skin of a patient as a colorless transparent gel.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: May 22, 2001
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6217904
    Abstract: Novel pharmaceutical dosage forms provide for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant, i.e., release encapsulated drug in spaced apart “pulses.” The second CNS stimulant may be an analeptic agent or a psychostimulant, with analeptic agents preferred. The dosage forms may comprise capsules housing compressed tablets or drug-containing beads or particles, or may comprise a tablet with the first, second and optionally third dosage units each representing an integral and discrete segment thereof. Methods of treatment using the pharmaceutical dosage forms are provided as well.
    Type: Grant
    Filed: April 6, 2000
    Date of Patent: April 17, 2001
    Assignee: Pharmaquest Ltd.
    Inventors: Kamal K. Midha, Martin H. Teicher
  • Patent number: 6214373
    Abstract: A nutritional composition and method useful for treatment of inflammatory bowel diseases is disclosed, the composition comprising selected vitamins and mineral salts for oral administration to a subject having an inflammatory bowel disease. The composition comprises an excess of vitamin D and vitamin B12, contains vitamin C and iron in quantities promoting good absorption, contains water miscible forms of the fat soluble vitamins, and no phosphate or carbonate salts. Preferably, the iron is present as ferrous fumarate. And, preferably the composition is essentially free of magnesium.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: April 10, 2001
    Assignee: Snowden-Sutton Associates, Inc.
    Inventor: Robert B. Snowden
  • Patent number: 6210698
    Abstract: Compositions for suppositories comprising (A) a fatty base, (B) monodecanoyl-glycerol, (C) monolauroyl-glycerol, (D) a powder insoluble in fatty base and (E) a drug for suppositories capable of giving highly useful suppositories which sustain a melting point higher than the body temperature under dry storage conditions and thus remain stable without melting during storage but, when inserted into body cavity, quickly melt or gel.
    Type: Grant
    Filed: April 6, 2000
    Date of Patent: April 3, 2001
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Masaru Yamazaki, Soichi Itoh, Seiichi Hori, Tomoko Fujimori, Katsuyoshi Aikawa